In this time of dire need, Sepragen team is doing its part to solve the problem of COVID-19. We are providing equipment on an expedited basis to a company developing a vaccine for COVID- 19.
Product selector tool

Select all that is applicable

Cell Culture Harvest Volume or Buffer Volume January 24th 2019, Union City, CA. Sepragen Corporation announced today it had successfully completed research using a grant from the National Science Foundation to demonstrate the feasibility of using a "wicking" matrix bioreactor (WMB) for expansion of hiPSCs for tissue engineering and regenerative medicine applications.
Single-use (choose one) January 24th 2019, Union City, CA. Sepragen Corporation announced today it had successfully completed research using a grant from the National Science Foundation to demonstrate the feasibility of using a "wicking" matrix bioreactor (WMB) for expansion of hiPSCs for tissue engineering and regenerative medicine applications.
Continuous (choose one) January 24th 2019, Union City, CA. Sepragen Corporation announced today it had successfully completed research using a grant from the National Science Foundation to demonstrate the feasibility of using a "wicking" matrix bioreactor (WMB) for expansion of hiPSCs for tissue engineering and regenerative medicine applications.
Inline Buffer Dilution (choose one) January 24th 2019, Union City, CA. Sepragen Corporation announced today it had successfully completed research using a grant from the National Science Foundation to demonstrate the feasibility of using a "wicking" matrix bioreactor (WMB) for expansion of hiPSCs for tissue engineering and regenerative medicine applications.
Inline Buffer Blending (choose one) January 24th 2019, Union City, CA. Sepragen Corporation announced today it had successfully completed research using a grant from the National Science Foundation to demonstrate the feasibility of using a "wicking" matrix bioreactor (WMB) for expansion of hiPSCs for tissue engineering and regenerative medicine applications.
Radial Flow Column (choose one) January 24th 2019, Union City, CA. Sepragen Corporation announced today it had successfully completed research using a grant from the National Science Foundation to demonstrate the feasibility of using a "wicking" matrix bioreactor (WMB) for expansion of hiPSCs for tissue engineering and regenerative medicine applications.
Perfusion January 24th 2019, Union City, CA. Sepragen Corporation announced today it had successfully completed research using a grant from the National Science Foundation to demonstrate the feasibility of using a "wicking" matrix bioreactor (WMB) for expansion of hiPSCs for tissue engineering and regenerative medicine applications.
Maximum System Flowate January 24th 2019, Union City, CA. Sepragen Corporation announced today it had successfully completed research using a grant from the National Science Foundation to demonstrate the feasibility of using a "wicking" matrix bioreactor (WMB) for expansion of hiPSCs for tissue engineering and regenerative medicine applications.
Column Diameter January 24th 2019, Union City, CA. Sepragen Corporation announced today it had successfully completed research using a grant from the National Science Foundation to demonstrate the feasibility of using a "wicking" matrix bioreactor (WMB) for expansion of hiPSCs for tissue engineering and regenerative medicine applications.